Insiders Acarix AB

Equities

Delayed Nasdaq Stockholm Other stock markets 10:00:29 2024-06-03 am EDT			5-day change	1st Jan Change
0.3155 ^SEK	+1.94%		-3.07%	+66.23%

May. 27	Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	CI
May. 14	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024

Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	May. 27	CI
Acarix AB Approves Board Elections	May. 14	CI
Acarix Appoints New Members to the Advisory Board	Feb. 15	CI
Acarix Names New CEO	Feb. 01	MT
Acarix AB Announces CEO Changes	Feb. 01	CI
Acarix CEO to Take Medical Leave; Acting CEO Appointed	23-10-03	MT
Acarix AB Announces CEO Changes	23-10-02	CI
Acarix AB Appoints Christian Lindholm as Executive Vice President	23-10-02	CI
Acarix AB Appoints Dr. Deepak R. Talreja Md as New Medical Advisor	23-08-28	CI
Acarix AB Elects Mikael Thorén as Director	23-05-11	CI
Acarix CEO Joins Pharmacolog in Same Role	23-01-09	MT
Acarix : Nomination committee	22-04-11	PU
Acarix : newly appointed CEO Helen Ljundahl Round interview on strategic focus and execution (interview in Swedish)	22-01-21	PU
Acarix AB Appoints Helen Ljungdahl Round as New CEO	22-01-10	CI
Acarix Appoints Helen Ljungdahl Round as President Acarix Inc	21-09-28	CI
Acarix Recruits Helen Ljungdahl Round as Head of the Company’s Newly Established Us Subsidiary Acarix Inc	21-09-14	CI
Acarix AB Announces Board Changes	21-04-12	CI
Acarix AB Announces Executive Changes	20-05-14	CI
Acarix AB Announces Board Changes	19-05-20	CI
Acarix AB Appoints Per Perrson as Chief Executive Officer	18-11-13	CI

No results for this search